Financing channel feed

A new George Church start­up rais­es $16M. The first-time founders have a ‘crazy vi­sion’ to bring ML to cell ther­a­py

2 hours ago
Startups

Tol­re­mo rais­es $39M Se­ries A to ad­vance drug de­signed to dis­man­tle ear­ly can­cer de­fens­es

Yesterday
Startups

RNA edit­ing start­up launch­es with $30M based on Stan­ford and Uni­ver­si­ty of Tübin­gen re­search

2 days ago
Startups
Cell/Gene Tx

With co­va­lent meds abuzz, RA Cap­i­tal and No­var­tis lead $56M seed round for new start­up

2 days ago
Startups

Stu­art Schreiber start­up launch­es with $50M to take mol­e­c­u­lar glue med­i­cines be­yond pro­tein degra­da­tion

2 days ago

Ex­clu­sive: Backed by for­mer Google CEO’s VC, a Col­orado biotech hatch­es plat­form to evolve de­graders

2 days ago
R&D

CD­MOs Nephron and Can­ton each raise hun­dreds of mil­lions in fi­nanc­ing

2 days ago
Manufacturing

BioN­Tech nabs up to $90M for mpox vac­cine as it be­gins PhI/II tri­al be­hind Mod­er­na's lead

2 days ago
R&D
Pharma

Ex­clu­sive: Backed by Il­lu­mi­na, Bro­ken String Bio­sciences rais­es $15M to find off-tar­get gene ed­its

3 days ago
R&D

Neumo­ra, Rayze­Bio ride on­to Nas­daq in IPO dou­ble­head­er, breath­ing life in­to fall list­ings

6 days ago
Startups

Flag­ship’s AI uni­corn Gen­er­ate rais­es $273M Se­ries C, as first drug in 17-pro­gram pipeline en­ters the clin­ic

Last week
AI

Af­ter an $80M Se­ries D raise, Dal­Cor takes an­oth­er shot at a PhI­II my­ocar­dial in­farc­tion tri­al

Last week
R&D

Rock­et Phar­ma­ceu­ti­cals says FDA agrees to 12-pa­tient study for ac­cel­er­at­ed ap­proval, ex­pects to raise $175M

Last week
FDA+

Ex­clu­sive: Phar­ma­cy ad­her­ence start­up Sem­pre Health rais­es $20M

Last week
Startups
Health Tech

Mironid reach­es $43.7M to date in Se­ries A ex­ten­sion to fund kid­ney dis­ease treat­ment stud­ies

Last week
R&D

Aval­on's lat­est biotech clos­es $58M round as it pur­sues treat­ments for au­toim­mune brain con­di­tions

Last week

Renibus brings Se­ries B to­tal to $72M, se­cur­ing reg­is­tra­tional de­vel­op­ment for lead heart surgery can­di­date

Last week

Rome Ther­a­peu­tics ad­vances dark genome drug af­ter com­plet­ing $72M Se­ries B ex­ten­sion backed by Big Phar­ma

Last week
R&D

Ac­tio locks in $55M Se­ries A raise to ad­vance rare dis­ease pipeline based on hu­man ge­net­ic plat­form

Last week
R&D

Chi­nese cell ther­a­py biotech de­vel­op­ing TIL ther­a­pies rais­es $60M Se­ries B

Last week
China

For­mer Google AI leader lands $100M Se­ries A raise for 'bi­o­log­i­cal soft­ware' start­up

Last week

Mar­i­ana On­col­o­gy, a ra­dio­phar­ma start­up found­ed by top-tier VCs, nabs $175M Se­ries B

2 weeks ago

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

2 weeks ago
Startups

French biotech Cor­te­ria se­cures $70M to re­vive ex-Sanofi heart drugs 

2 weeks ago
1234 Next page Last page
A service from the Financial Times